These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6991320)

  • 1. Insulin resistance in obesity as analyzed by the response of glucose kinetics to glucagon infusion.
    Vranic M; Morita S; Steiner G
    Diabetes; 1980 Mar; 29(3):169-76. PubMed ID: 6991320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.
    Prager R; Wallace P; Olefsky JM
    J Clin Invest; 1986 Aug; 78(2):472-81. PubMed ID: 3525609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to insulin but not to glucagon in lean human hypertriglyceridemics.
    Steiner G; Morita S; Vranic M
    Diabetes; 1980 Nov; 29(11):899-905. PubMed ID: 7000587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus.
    Kimmerling G; Javorski C; Olefsky JM; Reaven GM
    Diabetes; 1976 Aug; 25(8):673-8. PubMed ID: 955298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic glucagon response to glucose in obesity with normal and impaired carbohydrate tolerance.
    Ratzmann KP; Schulz B; Witt S; Ziegler M
    Int J Obes; 1981; 5(2):163-9. PubMed ID: 7014481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.
    Bergman RN; Phillips LS; Cobelli C
    J Clin Invest; 1981 Dec; 68(6):1456-67. PubMed ID: 7033284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response.
    Doeden B; Rizza R
    J Clin Endocrinol Metab; 1987 May; 64(5):902-8. PubMed ID: 3549759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject.
    Kolanowski J; Salvador G; Desmecht P; Henquin JC; Crabbé J
    Eur J Clin Invest; 1977 Jun; 7(3):167-75. PubMed ID: 408142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance.
    Reaven GM; Moore J; Greenfield M
    Diabetes; 1983 Jul; 32(7):600-4. PubMed ID: 6345239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
    Smith GC; Vickers MH; Cognard E; Shepherd PR
    Schizophr Res; 2009 Nov; 115(1):30-40. PubMed ID: 19679451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
    Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
    Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
    Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
    J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carbohydrate intolerance during complete fasting].
    Göschke H; Thölen H
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1847-50. PubMed ID: 337474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.
    Toft-Nielson M; Madsbad S; Holst JJ
    Diabetes; 1996 May; 45(5):552-6. PubMed ID: 8621002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased glucose tolerance in N-type Ca2+ channel alpha(1B)-subunit gene-deficient mice.
    Takahashi E; Ito M; Miyamoto N; Nagasu T; Ino M; Tanaka I
    Int J Mol Med; 2005 Jun; 15(6):937-44. PubMed ID: 15870896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.